Scrip discusses the latest M&A activity and trends with CEO Shawn Titcomb of Allele Capital and Cheryl Reicin, a partner focused on international life sciences activity at Mintz.

Scrip discusses the latest M&amp;A activity and trends with CEO Shawn Titcomb of Allele Capital and Cheryl Reicin, a partner focused on international life sciences activity at Mintz.

Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Share Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’

Sign up to save your podcasts

Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’

Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’

More shows like Citeline Podcasts

The Documentary Podcast

Nature Podcast

Economist Podcasts

Marketplace

Marketplace All-in-One

Exchanges

Decoder with Nilay Patel

The Long Run with Luke Timmerman

The Readout Loud

FT News Briefing

The Intelligence from The Economist

The Rachman Review

BioCentury This Week

Biotech Hangout

Money Stuff: The Podcast